Braveheart Bio (BRVE) Insider Trading

Officer, director, and 10%+ owner transactions reported to the SEC on Form 4, with buy/sell totals and cluster activity for Braveheart Bio.

Bought (12 mo) $124,114,950
Sold (12 mo) $0
Insiders Buying (12 mo) 10
Insiders Selling (12 mo) 0
Form 4 Filings (All Time) 14
Most Recent Purchase
August 11, 2026
Ah Bio Fund IV, L.P. 10%+
$19,800,000
Buys (90d) 0
Sells (90d) 0
Recent Insider Transactions
Recent insider transactions
Filed Insider Role Type Value % Change
2026-08-11 Orbimed Advisors Llc Director Buy $34,920,000 +1335.0%
2026-08-11 Ah Bio Fund Iv, L.P. 10%+ Buy $19,800,000 —
2026-08-11 Chimovits Erez Director Buy $34,920,000 +1335.0%
2026-08-10 Jiangsu Hengrui Pharmaceuticals Co., Ltd. 10%+ Other — —
2026-08-07 Murdoch Travis CEO Buy $1,499,994 +1.0%
2026-08-07 Forbion Growth Opportunities Fund Iii Cooperatief U.A. 10%+ Buy $64,800,000 +1879.3%
2026-08-07 Anderson Michele A. Officer Buy $19,998 +0.3%
2026-08-07 Lubner David Charles Director Buy $999,990 —
2026-08-07 Chimovits Erez Director Award — —
2026-08-07 Bos Jasper Director Award — —
2026-08-07 Lohoff Tim Director Award — —
2026-08-07 Viehbacher Christopher Director Buy $1,499,994 +12.3%
2026-08-07 Rickey James Paul CFO Buy $499,986 +4.1%
2026-08-07 Malek David I Director Buy $74,988 +0.4%